Although expression of CA-CaMKII did not induce leukemia development on its own, increased CaMKII activity was associated with new progression to hematologic malignancy on a tp53 predisposition background, indicating it functions as an additional “hit” during transformation. This evidence concerns the gene TP53 and leukemia.